Posts tagged 'Counterparty Risk'

Banks getting taste of own medicine from CCPs prove unable to suppress gag reflex

Ohhh, who’s being naughty now? Read more

UBS moves counterparty risk outside regulatory net

What’s a bank to do when it has to sit on exposures that it doesn’t like?

Sell them of course! Especially if those exposures are expensive to hedge and costly in terms of regulatory capital charges. Read more

The Bank of England gets economical with its derivatives

Isn’t it annoying when particular clients insist on being treated differently to everyone else? Like, just because your client is well, England, or Italy, or some other sovereign nation, doesn’t make them ‘special’. It’s also kind of annoying when they make regulations that make business tougher for banks and then still expect to be treated differently.

Interestingly though, the Bank of England just stopped asking for one such special exception when it comes to certain derivatives that it enters into on behalf of the nation in order to best manage its balance sheet and the Treasury’s foreign exchange reserves. Read more

Decoding the latest OTC derivative BIStimates

Just when someone’s gone and put a decent dataset together, someone has to go and mess it up. Thanks, Spain and Australia. Really, thank you. None of us really cared that much anyway about the data being comparable from one period to the next. Whatevs.

– FT Alphaville’s Internal Monologue Read more

The FSA takes pre-emptive action on liquidity swaps

Bank of England: Hey, FSA guys, don’t mean to tell how to do your job, but pssst! look at “collateral swaps” ok?
FSA: Collateral swaps? Do you mean “liquidity swaps”? We don’t think even Dodd-Frank looks at those..
Bank of England: Look at them anyway. We’ll be your overlords direct colleagues soon, so get on with it.
[several months pass]
FSA: We blocked some!! We blocked some!!

Alright, it probably didn’t go down like that, but FT Alphaville enjoys pretending it did. Read more

What to do with all that cash?

Use it as collateral of course.

We refer, of course, to the massive cash reserves built up by banks due to quantitative easing. Reserves which, as most deflationistas point out, have been stuck firmly on banks’ balance sheets rather than making their way through to the real economy — thus supposedly having little inflationary impact. Read more

An unusual letter from the Fed, an unwinding of hedges

That’s a sudden spike in trade volume right around Tuesday of this week. As a reminder, this index tracks CDS on 125 investment-grade names, including the monoline MBIA. Read more

An update from S&P’s covered bond wars

A bad day for Standard & Poor’s.

Two rating withdrawal requests before lunchtime: Read more

The levelling-off in OTC derivatives

Fresh from the Bank for International Settlements – lots and lots of derivatives statistics.

And according to the central bank’s bank, growth in the OTC derivatives market has rather slowed. Positions went up in the three years since their last Triennial survey (+15 per cent, or 5 per cent annualised) to $583,000bn, but that’s nothing compared to growth in the previous (2004-2007 period) or 131 per cent, or 32 per cent a year. Read more

Some ECB refinements

It’s no secret the European central bank is none too pleased with some of the Asset-Backed Securities (ABS) being pledged by banks as collateral at its liquidity ops, reports FT Alphaville. Welcome then, the ECB’s fine-tuning (ha) of its General Documentation, the thing that governs the implementation of monetary policy in the eurozone. In its latest revision, announced on Friday, the central bank has tightened-up ABS collateral rules, and given itself the power to “suspend, limit or exclude” a defaulting or ‘imprudent’ counterparty. Read more

Basel takes aim at the negative basis

Basel is busy bolting stable doors.

Indeed, one of the big drivers behind new Basel III counterparty risk capital requirements is the infamous negative basis tradeRead more

Missing links

We’re just making our way through the new BIS quarterly review, but here’s a lovely piece of chart porn that caught our eye:

 Read more

Will derivatives reform take us from CCPs to GSEs?

Confused about just how the Dodd-Frank Act would actually change derivatives markets? Happily, Barclays Capital’s Rajiv Setia and team have tried an answer.

Not so happily, the answer is a bit disconcerting. Read more

The BoE turns its attention to ETFs (updated)

The Bank of England’s latest financial stability report has turned its attention to the increasingly cumbersome issue of Exchange-Traded Funds (ETFs), which have recently come in for some criticism over their growing complexity and lack of transparency.

As the Bank notes, the products do offer some great advantages to the market. Read more

Vigilant traders push on with business as usual

Oil trading houses and large banks were watching their exposure to BP closely yesterday but said they continued trading as usual in spite of the company’s woes, the FT reports. “No change but watching carefully,” said an executive at one of the five largest oil trading companies. A senior trader at another big company added: “We are monitoring it closely, but trade remains as normal.” BP is central to commodities markets such as oil, gasoline and natural gas. It is the largest trader among the big oil companies, with far more complex activities on physical and derivatives markets than rivals such as ExxonMobil.

Broker calls for OTC rethink

Plans to force over-the-counter trading of derivatives on to exchanges to reduce counterparty risk need to be rethought by regulators, according to the Asia head of one of the world’s biggest brokers. Pierre Gay, Asia-Pacific chief executive of futures broker Newedge, said the creation of a central clearing house to act as counterparty to OTC transactions on exchanges could be dangerous because it would transfer risk from banks to the clearer.